ArticlePloS one2013

Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer.

Jianzhong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.